FR16C1003I2 - Agent oleogelifiant contenant du triterpene, oleogel contenant du triterpene et procede de fabrication d'un agent oleogelifiant contenant du triterpene - Google Patents

Agent oleogelifiant contenant du triterpene, oleogel contenant du triterpene et procede de fabrication d'un agent oleogelifiant contenant du triterpene

Info

Publication number
FR16C1003I2
FR16C1003I2 FR16C1003C FR16C1003C FR16C1003I2 FR 16C1003 I2 FR16C1003 I2 FR 16C1003I2 FR 16C1003 C FR16C1003 C FR 16C1003C FR 16C1003 C FR16C1003 C FR 16C1003C FR 16C1003 I2 FR16C1003 I2 FR 16C1003I2
Authority
FR
France
Prior art keywords
oleogelling
containing triterpene
agent containing
triterpene
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR16C1003C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amryt GmbH
Original Assignee
Birken AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR16C1003(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Birken AG filed Critical Birken AG
Publication of FR16C1003I1 publication Critical patent/FR16C1003I1/fr
Application granted granted Critical
Publication of FR16C1003I2 publication Critical patent/FR16C1003I2/fr
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/37Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings
    • C07C35/42Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings derived from the phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Colloid Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Volume Flow (AREA)
FR16C1003C 2004-06-22 2016-07-11 Agent oleogelifiant contenant du triterpene, oleogel contenant du triterpene et procede de fabrication d'un agent oleogelifiant contenant du triterpene Active FR16C1003I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004030044A DE102004030044A1 (de) 2004-06-22 2004-06-22 Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
PCT/EP2005/006710 WO2005123037A1 (de) 2004-06-22 2005-06-21 Triterpenhaltiger oleogelbildner, triterpenhaltiges oleogel und verfahren zur herstellung eines triterpenhaltigen oleogels

Publications (2)

Publication Number Publication Date
FR16C1003I1 FR16C1003I1 (no) 2016-08-26
FR16C1003I2 true FR16C1003I2 (fr) 2018-01-19

Family

ID=34971468

Family Applications (1)

Application Number Title Priority Date Filing Date
FR16C1003C Active FR16C1003I2 (fr) 2004-06-22 2016-07-11 Agent oleogelifiant contenant du triterpene, oleogel contenant du triterpene et procede de fabrication d'un agent oleogelifiant contenant du triterpene

Country Status (31)

Country Link
US (2) US8536380B2 (no)
EP (1) EP1758555B2 (no)
JP (1) JP4468987B2 (no)
KR (1) KR101162991B1 (no)
CN (1) CN1972668B (no)
AT (1) ATE423546T1 (no)
AU (1) AU2005253732C1 (no)
BE (1) BE2016C035I2 (no)
BR (1) BRPI0512288B8 (no)
CA (1) CA2571606C (no)
CY (2) CY1109066T1 (no)
DE (2) DE102004030044A1 (no)
DK (1) DK1758555T4 (no)
ES (1) ES2323082T5 (no)
FR (1) FR16C1003I2 (no)
HU (1) HUS1600032I1 (no)
IL (1) IL180057A (no)
LT (1) LTC1758555I2 (no)
LU (1) LU93142I2 (no)
MX (1) MXPA06015233A (no)
NL (1) NL300823I2 (no)
NO (2) NO336747B1 (no)
NZ (1) NZ552280A (no)
PL (1) PL1758555T5 (no)
PT (1) PT1758555E (no)
RS (1) RS50832B2 (no)
RU (1) RU2430717C2 (no)
SI (1) SI1758555T2 (no)
UA (1) UA88308C2 (no)
WO (1) WO2005123037A1 (no)
ZA (1) ZA200610304B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2332525A1 (en) 2009-11-23 2011-06-15 Novaliq GmbH Pharmaceutical composition comprising propofol
DE102009047092A1 (de) 2009-11-24 2011-05-26 Birken Gmbh Verwendung eines triterpenhaltigen Oleogels zur Wundheilung
PL2335675T3 (pl) 2009-12-10 2015-08-31 Neubourg Skin Care Gmbh & Co Kg Wolne od emulgatorów, stabilizowane polimerem formulacje pianki
PL2363108T3 (pl) 2010-03-02 2018-04-30 Neubourg Skin Care Gmbh & Co. Kg Formulacje piankowe zawierające co najmniej jeden triterpenoid
WO2012177825A1 (en) 2011-06-21 2012-12-27 Bvw Holding Ag Medical device comprising boswellic acid
US20190281853A1 (en) * 2016-05-12 2019-09-19 Rudjer Boskovic Institute Low molecular weight organic gelators of vegetable oil
JP2019524755A (ja) * 2016-07-18 2019-09-05 アムリット・リサーチ・リミテッド ベツリン含有油中水型泡沫及びその組成物
WO2018165505A1 (en) * 2017-03-10 2018-09-13 Kraton Polymers U.S. Llc Fusible oil gel compositions and methods of making and using same
KR102692754B1 (ko) 2017-08-31 2024-08-08 (주)아모레퍼시픽 병풀 추출물 또는 이로부터 유래한 트리테르펜을 고함량으로 포함하는 화장료 조성물 및 이의 제조 방법
EP3973973A1 (en) 2017-10-31 2022-03-30 KaliVir Immunotherapeutics, Inc. Platform oncolytic vector for systemic delivery
SG11202003668YA (en) 2018-01-04 2020-05-28 Amryt Res Limited Betulin-containing birch bark extracts and their formulation
CN113164384A (zh) 2018-10-26 2021-07-23 维拉莫有限公司 黏膜粘附性凝胶组合物
EP3659583B1 (en) 2018-11-30 2023-06-07 Viramal Limited A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent
CN109512780A (zh) * 2019-01-09 2019-03-26 河南省医药科学研究院 一种凝胶药膏及其制备方法和应用
GR1010072B (el) * 2019-05-15 2021-09-15 Αριστοτελειο Πανεπιστημιο Θεσσαλονικης - Ειδικος Λογαριασμος Κονδυλιων Ερευνας Βρωσιμα κτηνιατρικα σκευασματα ενδομαστικης προστασιας θηλαστικων και μεθοδος για την παρασκευη τους
CA3215344A1 (en) 2021-04-30 2022-11-03 Kalivir Immunotherapeutics, Inc. Oncolytic viruses for modified mhc expression

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83173A1 (fr) 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
JP3363161B2 (ja) 1991-06-27 2003-01-08 ポーラ化成工業株式会社 非水ゲル化粧料
US5750578A (en) 1997-02-11 1998-05-12 Regents Of The University Of Minnesota Use of betulin and analogs thereof to treat herpesvirus infection
US6403816B1 (en) * 1997-09-30 2002-06-11 Dabur Research Foundation Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
FR2779438B1 (fr) * 1998-06-03 2004-12-24 Jean Marc Aiache Gel stable, son procede de preparation, et compositions pharmaceutiques le comprenant
GB9908593D0 (en) * 1999-04-16 1999-06-09 Quest Int Dental compositions containing boswellia extracts
PT1200106E (pt) 1999-07-09 2003-09-30 Bsp Pharma As Composicao contendo extractos de butyrospermum parkii e utilizacao como medicamento ou suplemento dietetico
DE60102402T2 (de) 2000-02-10 2005-03-10 Loders Croklaan B.V. Fettmischungen mit Kristallmodifikatoren
EA006296B1 (ru) * 2000-03-28 2005-10-27 Биркен Гмбх Способ извлечения тритерпенов из бетулинсодержащих растений, эмульсия тритерпенов и ее применение
DE10056902A1 (de) * 2000-11-16 2002-05-23 Birken Gmbh Verfahren zur Gewinnung von Triterpenen aus Pflanzen sowie deren Verwendung
US6689767B2 (en) 2000-09-29 2004-02-10 Regents Of The University Of Minnesota Triterpenes having antibacterial activity
WO2002026761A1 (en) 2000-09-29 2002-04-04 Regents Of The University Of Minnesota Triterpenes having fungicidal activity against yeast
JP2002138014A (ja) 2000-10-31 2002-05-14 Noevir Co Ltd 微細エマルション組成物
DE10143964A1 (de) 2001-09-07 2003-03-27 Basf Ag Emulgatorarme oder emulgatorfreie Systeme vom Typ Öl-in-Wasser mit einem Gehalt an Stabilisatoren und einem aminosubstituierten Hydroxybenzophenon
DE10156297A1 (de) * 2001-11-19 2003-05-28 Henkel Kgaa Mittel zum Schutz der Haut
JP2003335627A (ja) 2002-03-14 2003-11-25 Lion Corp 化粧料含浸シート
DE10237281A1 (de) 2002-08-14 2004-03-04 Birken Gmbh Vorrichtung zur kontinuierlichen Extraktion von Extraktstoffen aus Pflanzen
JP3779661B2 (ja) 2002-09-13 2006-05-31 花王株式会社 皮膚化粧料
KR100489701B1 (ko) * 2002-10-09 2005-05-16 주식회사 태평양 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
JP2005004911A (ja) 2003-06-13 2005-01-06 Ikuta Insatsu Kk 磁気カード
DE10329955A1 (de) * 2003-07-03 2005-02-03 Merck Patent Gmbh Verwendung eines hydroalkoholischen Extrakts aus Bauhinia zur Herstellung einer Zubereitung

Also Published As

Publication number Publication date
RU2430717C2 (ru) 2011-10-10
CY2016025I2 (el) 2016-10-05
DE502005006701D1 (de) 2009-04-09
DK1758555T4 (da) 2011-12-19
BRPI0512288B8 (pt) 2021-05-25
IL180057A0 (en) 2007-05-15
CY2016025I1 (el) 2016-10-05
UA88308C2 (ru) 2009-10-12
KR20070046821A (ko) 2007-05-03
HUS1600032I1 (hu) 2016-08-29
CN1972668A (zh) 2007-05-30
ATE423546T1 (de) 2009-03-15
CY1109066T1 (el) 2014-07-02
CN1972668B (zh) 2013-01-09
EP1758555A1 (de) 2007-03-07
EP1758555B2 (de) 2011-09-07
JP4468987B2 (ja) 2010-05-26
AU2005253732C1 (en) 2010-01-21
AU2005253732A1 (en) 2005-12-29
DK1758555T3 (da) 2009-06-22
CA2571606C (en) 2011-07-19
BE2016C035I2 (no) 2024-10-08
LTC1758555I2 (lt) 2017-11-10
JP2008503530A (ja) 2008-02-07
KR101162991B1 (ko) 2012-07-10
FR16C1003I1 (no) 2016-08-26
WO2005123037A1 (de) 2005-12-29
RU2007102084A (ru) 2008-07-27
NL300823I2 (nl) 2017-06-22
NO2016012I2 (no) 2016-07-07
NO20070390L (no) 2007-03-16
MXPA06015233A (es) 2007-12-12
US8828444B2 (en) 2014-09-09
BRPI0512288B1 (pt) 2019-05-21
RS50832B (sr) 2010-08-31
NZ552280A (en) 2010-10-29
SI1758555T1 (sl) 2009-08-31
ES2323082T5 (es) 2012-01-05
US20140050790A1 (en) 2014-02-20
US20070299285A1 (en) 2007-12-27
BRPI0512288A (pt) 2008-03-25
CA2571606A1 (en) 2005-12-29
AU2005253732B2 (en) 2009-07-16
ZA200610304B (en) 2007-11-28
SI1758555T2 (sl) 2009-08-31
NO2016012I1 (no) 2016-07-07
PL1758555T5 (pl) 2011-12-30
DE102004030044A1 (de) 2006-01-12
ES2323082T3 (es) 2009-07-06
LU93142I2 (fr) 2016-09-06
PL1758555T3 (pl) 2009-07-31
RS50832B2 (sr) 2018-09-28
IL180057A (en) 2013-11-28
US8536380B2 (en) 2013-09-17
NO336747B1 (no) 2015-10-26
PT1758555E (pt) 2009-04-24
EP1758555B1 (de) 2009-02-25

Similar Documents

Publication Publication Date Title
FR16C1003I2 (fr) Agent oleogelifiant contenant du triterpene, oleogel contenant du triterpene et procede de fabrication d'un agent oleogelifiant contenant du triterpene
ATE459623T1 (de) Pyridoä2,3-düpyrimidine, die sich als hcv- inhibitoren eignen und verfahren zu deren herstellung
ATE419260T1 (de) C-aryl-glucosid-sglt2-inhibitoren und verfahren zu ihrer herstellung
DE602006012283D1 (de) Integrierte schaltung und verfahren zu ihrer herstellung
DE602005010658D1 (de) Lithografische Vorrichtung und Herstellungsverfahren
HK1127971A1 (en) Exposure method, exposure apparatus, photomask and photomask manufacturing method
FR2841631B1 (fr) Structure de raccord de tuyau et son procede de fabrication
FR2878769B1 (fr) Procede et dispositif de fabrication de tuyau rainure, et structure de celui-ci
FR2892196B1 (fr) Procede de fabrication d'un biocapteur a detection integree
DE602006012746D1 (de) Lithografische Vorrichtung und Herstellungsverfahren
ATE556077T1 (de) Tetrahydrochinolinderivate und verfahren zu deren herstellung
FR2883585B1 (fr) Dispositif d'etancheite pour le batiment et un procede pour sa fabrication
EP1783546A4 (en) SEMI-PORTABLE FILM, FOTOMASKENROHLING, PHOTOMASK AND METHOD FOR THE DESIGN OF A SEMI-PERMANENT FILM
FR2902566B1 (fr) Dispositif d'affichage et son procede de fabrication.
DE602005009246D1 (de) Lithografische Vorrichtung und Herstellungsverfahren dafür
FR2871060B1 (fr) Agent suppresseur pour l'inflammation et procede l'utilisant
FR2891664B1 (fr) Transistor mos vertical et procede de fabrication
TWI340302B (en) Lithographic rinse solution and resist-pattern forming method
EP1755152A4 (en) MEASURING METHOD, MEASURING EQUIPMENT, EXPOSURE METHOD, AND EXPOSURE EQUIPMENT
FR2887543B1 (fr) Composition du rdx et procede pour sa fabrication
DE602004014588D1 (de) Kupferlegierung und Verfahren zu deren Herstellung
GB0623486D0 (en) Organic thin film transistor and method for manufacturing the same
DE602004002122D1 (de) Doppelrohr und Verfahren zu dessen Herstellung
FR2883206B1 (fr) Procede de la fabrication d'un raccord de joint et raccord de joint
ITMI20051058A1 (it) "metodo e sistema per fabbricare componenti mediante elettroerosione"